Plasma metabolomic profiles of dementia: a prospective study of 110,655 participants in the UK Biobank
- PMID: 35965319
- PMCID: PMC9377110
- DOI: 10.1186/s12916-022-02449-3
Plasma metabolomic profiles of dementia: a prospective study of 110,655 participants in the UK Biobank
Abstract
Background: Plasma metabolomic profile is disturbed in dementia patients, but previous studies have discordant conclusions.
Methods: Circulating metabolomic data of 110,655 people in the UK Biobank study were measured with nuclear magnetic resonance technique, and incident dementia records were obtained from national health registers. The associations between plasma metabolites and dementia were estimated using Cox proportional hazard models. The 10-fold cross-validation elastic net regression models selected metabolites that predicted incident dementia, and a 10-year prediction model for dementia was constructed by multivariable logistic regression. The predictive values of the conventional risk model, the metabolites model, and the combined model were discriminated by comparison of area under the receiver operating characteristic curves (AUCs). Net reclassification improvement (NRI) was used to estimate the change of reclassification ability when adding metabolites into the conventional prediction model.
Results: Amongst 110,655 participants, the mean (standard deviation) age was 56.5 (8.1) years, and 51 186 (46.3%) were male. A total of 1439 (13.0%) developed dementia during a median follow-up of 12.2 years (interquartile range: 11.5-12.9 years). A total of 38 metabolites, including lipids and lipoproteins, ketone bodies, glycolysis-related metabolites, and amino acids, were found to be significantly associated with incident dementia. Adding selected metabolites (n=24) to the conventional dementia risk prediction model significantly improved the prediction for incident dementia (AUC: 0.824 versus 0.817, p =0.042) and reclassification ability (NRI = 4.97%, P = 0.009) for identifying high risk groups.
Conclusions: Our analysis identified various metabolomic biomarkers which were significantly associated with incident dementia. Metabolomic profiles also provided opportunities for dementia risk reclassification. These findings may help explain the biological mechanisms underlying dementia and improve dementia prediction.
Keywords: Dementia; Metabolites; UK Biobank.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



Similar articles
-
Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study.BMC Med. 2022 May 3;20(1):159. doi: 10.1186/s12916-022-02354-9. BMC Med. 2022. PMID: 35501852 Free PMC article.
-
Nuclear magnetic resonance-based metabolomics and risk of pancreatic cancer: a prospective analysis in the UK Biobank.J Gastroenterol. 2025 Jun;60(6):794-807. doi: 10.1007/s00535-025-02237-9. Epub 2025 Mar 12. J Gastroenterol. 2025. PMID: 40074913
-
Association of Metabolomics With Incidence of Age-Related Macular Degeneration: The UK Biobank Study.Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):43. doi: 10.1167/iovs.65.14.43. Invest Ophthalmol Vis Sci. 2024. PMID: 39739349 Free PMC article.
-
Risk factors, ethnicity and dementia: A UK Biobank prospective cohort study of White, South Asian and Black participants.PLoS One. 2022 Oct 12;17(10):e0275309. doi: 10.1371/journal.pone.0275309. eCollection 2022. PLoS One. 2022. PMID: 36223334 Free PMC article. Review.
-
Sense of meaning and purpose in life and risk of incident dementia: New data and meta-analysis.Arch Gerontol Geriatr. 2023 Feb;105:104847. doi: 10.1016/j.archger.2022.104847. Epub 2022 Oct 23. Arch Gerontol Geriatr. 2023. PMID: 36347158 Free PMC article.
Cited by
-
Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer's Disease.Metabolites. 2022 Oct 6;12(10):949. doi: 10.3390/metabo12100949. Metabolites. 2022. PMID: 36295851 Free PMC article.
-
Small molecule metabolites: discovery of biomarkers and therapeutic targets.Signal Transduct Target Ther. 2023 Mar 20;8(1):132. doi: 10.1038/s41392-023-01399-3. Signal Transduct Target Ther. 2023. PMID: 36941259 Free PMC article. Review.
-
Circulating metabolome in relation to cognitive impairment: a community-based cohort of older adults.Transl Psychiatry. 2024 Nov 11;14(1):469. doi: 10.1038/s41398-024-03147-9. Transl Psychiatry. 2024. PMID: 39528482 Free PMC article.
-
Causal Association between Circulating Metabolites and Dementia: A Mendelian Randomization Study.Nutrients. 2024 Aug 28;16(17):2879. doi: 10.3390/nu16172879. Nutrients. 2024. PMID: 39275195 Free PMC article.
-
Branched-chain amino acids and the risks of dementia, Alzheimer's disease, and Parkinson's disease.Front Aging Neurosci. 2024 Apr 10;16:1369493. doi: 10.3389/fnagi.2024.1369493. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38659706 Free PMC article.
References
-
- Tynkkynen J, Chouraki V, van der Lee SJ, Hernesniemi J, Yang Q, Li S, Beiser A, Larson MG, Saaksjarvi K, Shipley MJ, et al. Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: a prospective study in eight cohorts. Alzheimers Dement. 2018;14(6):723–733. doi: 10.1016/j.jalz.2018.01.003. - DOI - PMC - PubMed
-
- Prince MJ, Wimo A, Guerchet MM, Ali GC, Wu Y-T, Prina M. World Alzheimer Report 2015 - The Global Impact of Dementia. London: Alzheimer's Disease International; 2015.
-
- Varma VR, Oommen AM, Varma S, Casanova R, An Y, Andrews RM, O'Brien R, Pletnikova O, Troncoso JC, Toledo J, et al. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study. PLoS Med. 2018;15(1):e1002482. doi: 10.1371/journal.pmed.1002482. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical